Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma.

BMC Cancer · 2017 · PMC5440917 · PMID 28532396

Europe PMC DOI

hedged sentence

0.0360

closest p · 0.7× alpha

0.0360

boldest claim

The sentences

borderline significanceP = 0.036actually significant

However this result is limited by a low case number in each subgroup and showed a borderline significance: low risk subgroup P = 0.036, HR = 7.308, CI 95 1.168–45.703; other than low risk subgroup P = 0.027, HR = 7.442, CI 95 1.677–33.028, importantly due to multiple testing (k = 2) a P -value <0.025 is considered as statistically significant, Fig. 2a .

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.